Fundraising Fox
HemoSonics
Charlottesville, US · Virginia LLC · 100 employees on LinkedIn
Find your way into HemoSonics
493 people in our graph share verified history with the HemoSonics team — schools, employers, funds. One of them is your warm intro.
Lorenzo Thioneunlockedknows Francesco Viola · together at Politecnico di Milano (overlapped)
×9knows the team · via Politecnico di Milano
×2knows the team · via University of Virginia
HemoSonics develops FDA-cleared viscoelastic testing (VET) technology that provides real-time hemostasis data at the point of care for hospital teams managing bleeding in obstetric, trauma, and surgical settings. Its products support faster transfusion decisions and reduced blood product use in healthcare facilities.
Founders & leadership
FV
Francesco ViolaCo-founder · Chief Operating OfficerFrancesco Viola brings 15+ years of experience in medical device product development, R&D operations, and commercialization, including navigating regulatory approvals and global market adoption at HemoSonics.
TJ
Timothy J. FischerManager
WF
William F. WalkerManager
Board
JM
Josep ManentManager
WP
William P MoffittManager
MW
Mark WheelerBoard director
Reported raises · per SEC filings
Form D private placements$22.6M disclosed across 3 rounds · 2014–2017
▶$15MraisedFeb 2017 · 1 investors · Other Health CareRule 506(b)
▶$15MraisedFeb 2017 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William F. WalkerDirector
- Philippe BarrouxDirector
- Timothy FischerExecutive Officer, Director
- Antoine CoulotDirector
- William P. MoffittDirector
- Francesco ViolaExecutive Officer, Director
- Josep ManentDirector
- Mark WheelerDirector
- Offering amount
- $15M
- Amount sold
- $15M
- Sales commissions
- $1.1M
- Placement agents
- E. Hunterson Henrie, II
- First sale
- Jan 2017
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
▶$4MraisedAug 2016 · 34 investors · Other Health CareRule 506(b)
▶$4MraisedAug 2016 · 34 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Francesco ViolaDirector
- Timothy J. FischerExecutive Officer, Director
- William F. WalkerDirector
- William P MoffittDirector
- Mark WheelerDirector
- Josep ManentDirector
- Offering amount
- $8M
- Amount sold
- $4M
- First sale
- Nov 2015
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
▶$3.7MraisedAug 2016 · 29 investors · Other Health CareRule 506(b)
▶$3.7MraisedAug 2016 · 29 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark WheelerDirector
- Timothy J. FischerExecutive Officer, Director
- William P. MoffittDirector
- Francesco ViolaExecutive Officer, Director
- Josep ManentDirector
- William F. WalkerDirector
- Offering amount
- $6M
- Amount sold
- $3.7M
- First sale
- Jul 2014
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
HistoSonicsHistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients. The company markets its technology to healthcare providers internationally.
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Companies working in the same space as HemoSonics.
Non-dilutive funding · 11 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of DefenseDefense Health Program | Phase II | 2017 | $500K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2015 | $2M |
| Department of DefenseDefense Health Program | Phase II | 2015 | $999.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $224.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $202.9K |
| Department of DefenseDefense Health Program | Phase I | 2014 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $2.2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2011 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2010 | $317.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2010 | $298.6K |
| U.S. NavyNavy | Phase ISTTR | 2010 | $70K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does HemoSonics do?
- HemoSonics develops FDA-cleared viscoelastic testing (VET) technology that provides real-time hemostasis data at the point of care for hospital teams managing bleeding in obstetric, trauma, and surgical settings. Its products support faster transfusion decisions and reduced blood product use in healthcare facilities.
- Who founded HemoSonics?
- HemoSonics was founded by Francesco Viola, Timothy J. Fischer, William F. Walker.
- How much funding has HemoSonics raised?
- HemoSonics has disclosed $22.6M raised across 3 rounds.
- Where is HemoSonics headquartered?
- HemoSonics is headquartered in Charlottesville, US.